What is he best known for?
The fields of study he is best known for:
- Gene
- Internal medicine
- Cancer
Ralf Paschke mainly focuses on Internal medicine, Endocrinology, Insulin resistance, Thyroid and Thyroid nodules.
He combines subjects such as Mutation, Germline mutation and Germline with his study of Endocrinology.
Ralf Paschke interconnects 3T3-L1, Adipocyte and Downregulation and upregulation in the investigation of issues within Insulin resistance.
His Thyroid research is multidisciplinary, relying on both Radiology and Etiology.
His Thyroid nodules research incorporates themes from Fine-needle aspiration, Follicular thyroid cancer and Nodule.
His Receptor study combines topics from a wide range of disciplines, such as Thyrotropin receptor and Cell biology.
His most cited work include:
- American Association of Clinical Endocrinologists, Associazione Medici Endocrinologi, and European Thyroid Association Medical Guidelines for Clinical Practice for the Diagnosis and Management of thyroid Nodules (785 citations)
- Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial (745 citations)
- Hormonal regulation of adiponectin gene expression in 3T3-L1 adipocytes. (587 citations)
What are the main themes of his work throughout his whole career to date?
Ralf Paschke mainly investigates Internal medicine, Endocrinology, Thyroid, Thyroid nodules and Receptor.
His study in Internal medicine is interdisciplinary in nature, drawing from both Downregulation and upregulation and Oncology.
His Endocrinology research is multidisciplinary, incorporating elements of Mutation and Germline mutation.
The Thyroid study which covers Pathology that intersects with Thyroid carcinoma.
His study looks at the intersection of Receptor and topics like Cell biology with Mutant.
The various areas that Ralf Paschke examines in his Insulin resistance study include Adipocyte, Type 2 diabetes and Forskolin.
He most often published in these fields:
- Internal medicine (58.24%)
- Endocrinology (50.85%)
- Thyroid (31.82%)
What were the highlights of his more recent work (between 2011-2020)?
- Thyroid (31.82%)
- Pathology (18.18%)
- Internal medicine (58.24%)
In recent papers he was focusing on the following fields of study:
Ralf Paschke focuses on Thyroid, Pathology, Internal medicine, Thyroid cancer and Fine-needle aspiration.
The concepts of his Thyroid study are interwoven with issues in Hormone, Germline mutation and Radiology, Nodule.
The various areas that Ralf Paschke examines in his Pathology study include Cancer and Thyroid carcinoma.
His Internal medicine study combines topics in areas such as Endocrinology and Oncology.
His Endocrinology research includes elements of Receptor and Transmembrane domain.
He studied Thyroid cancer and Surgery that intersect with RAS Mutation.
Between 2011 and 2020, his most popular works were:
- Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial (745 citations)
- 2013 European Thyroid Association Guidelines for Cervical Ultrasound Scan and Ultrasound-Guided Techniques in the Postoperative Management of Patients with Thyroid Cancer (167 citations)
- Fine-needle aspiration diagnoses of noninvasive follicular variant of papillary thyroid carcinoma. (82 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Internal medicine
- Cancer
The scientist’s investigation covers issues in Thyroid, Thyroid carcinoma, Pathology, Thyroid cancer and Internal medicine.
In general Thyroid, his work in Thyroid nodules is often linked to Indeterminate linking many areas of study.
His work in the fields of Pathology, such as Cytology and Malignancy, overlaps with other areas such as PAX8.
His Thyroid cancer study combines topics from a wide range of disciplines, such as Radiology and Surgery, Postoperative management.
Lenvatinib is closely connected to Oncology in his research, which is encompassed under the umbrella topic of Internal medicine.
His Follicular thyroid cancer study is concerned with the larger field of Endocrinology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
